2020 annual financial data
Sutro Biopharma 2020 Operating cash flow
Direct answer
Operating cash flow was -67.8M USD.
Operating income was -71.06M USD and net income was -32.13M USD.
Operating cash flow was -67.8M USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42.72M USD
- Operating income
- -71.06M USD
- Net income
- -32.13M USD
- Operating cash flow
- -67.8M USD